NEW YORK (GenomeWeb) – Invitae said after the close of the market on Monday that it plans to offer $50 million in shares of its common stock in a public offering.

Based on a stock price of $7.02 per share, the last reported sale price of its stock on March 23, Invitae said in a prospectus filed with the US Securities and Exchange Commission that it anticipates offering 7,122,507 shares. The company also plans to give underwriters a 30-day option to purchase up to an additional $7.5 million of shares of its common stock at the public offering price.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.